🇺🇸 FDA
Patent

US 10137212

Tetrahydroxamate chelators of zirconium89 and niobium90 for use in diagnostic applications

granted A61KA61K51/04A61K51/044

Quick answer

US patent 10137212 (Tetrahydroxamate chelators of zirconium89 and niobium90 for use in diagnostic applications) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K51/04, A61K51/044, A61K51/0472, A61K51/0474